Paul Elliott - Epidemiology

Author Information

Paul Elliott is a prominent researcher in the field of epidemiology and biostatistics. He is affiliated with the Department of Epidemiology and Biostatistics at Imperial College London, London, UK. His work primarily focuses on understanding the relationships between diet, environmental exposures, and various health outcomes, especially cardiovascular diseases and metabolic disorders.

Research Contributions

Paul Elliott has made significant contributions to epidemiology through numerous high-impact research studies. His recent work includes studies on the interactions between dietary patterns and blood pressure, the impact of household air pollution on cognitive impairment, and the effects of salt substitutes on blood pressure and clinical outcomes. Additionally, he has explored genetic loci associated with liver enzymes, metabolic phenotyping in relation to cardiovascular diseases, and the role of body mass index and waist-to-hip ratio in cardiovascular outcomes. His research employs advanced techniques such as metabolomics and Mendelian randomization to uncover pathways and risk factors associated with various health conditions.

Aliases

Paul Elliott is also known by the aliases P Elliott and P. Elliott.

Publication and Citation Metrics

Metric	Value
Citation Count	77,647
h-index	127
Paper Count	560

Publications:

Blood pressure interactions with the DASH dietary pattern, sodium, and potassium: The International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP).

DOI: 10.1093/ajcn/nqac067

Year: 2022

Household air pollution from solid fuel use as a dose-dependent risk factor for cognitive impairment in northern China

DOI: 10.1038/s41598-022-10074-6

Year: 2022

EFFECTS OF SALT SUBSTITUTES ON BLOOD PRESSURE AND CLINICAL OUTCOMES IN DIFFERENT POPULATION GROUPS: A SYSTEMATIC REVIEW AND META-ANALYSIS

DOI: 10.1016/s0735-1097(22)02445-7

Year: 2022

Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes

DOI: 10.1038/s41467-021-22338-2

Year: 2021

Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings

DOI: 10.1136/heartjnl-2019-315615

Year: 2021

Abstract MP09: Untargeted 1 H Nmr Metabolomics Metabolomic Analysis Reveals Pathways Of Protection Between Mediterranean-style Diet And Incident Cardiovascular Disease In The Multi-ethnic Study Of Atherosclerosis.

DOI: 10.1161/CIRC.143.SUPPL_1.MP09

Year: 2021

Risk factors mediating the effect of body mass index and waist-to-hip ratio on cardiovascular outcomes: Mendelian randomization analysis

DOI: 10.1038/s41366-021-00807-4

Year: 2021

Strategy for improved characterization of human metabolic phenotypes using a COmbined Multi-block Principal components Analysis with Statistical Spectroscopy (COMPASS)

DOI: 10.1093/bioinformatics/btaa649

Year: 2021

URINARY METABOLIC PHENOTYPE OF BLOOD PRESSURE

DOI: 10.1097/01.HJH.0000745100.86512.60

Year: 2021

Author Correction: Nutriome–metabolome relationships provide insights into dietary intake and metabolism

DOI: 10.1038/S43016-021-00309-6

Year: 2021

Who was Jonas Salk?

How Does Alcohol and Drug Involvement Affect Society?

What are the Long-Term Effects of Ionizing Radiation?

What are Some Examples of Geospatial Tracking in Epidemiology?

What is the K Series?

How are Behavioral Biometrics Relevant to Epidemiology?

What are the Challenges in Managing Drug Resistant TB?

How Can Healthcare Providers Build a Strong Therapeutic Alliance?

What Are the Challenges in Studying Physical Conditions?

What Role Does Z Score Play in Risk Assessment?

Partnered Content Networks

Relevant Topics